2011
DOI: 10.1038/jcbfm.2011.101
|View full text |Cite
|
Sign up to set email alerts
|

The KCa3.1 Blocker TRAM-34 Reduces Infarction and Neurological Deficit in a Rat Model of Ischemia/Reperfusion Stroke

Abstract: Supplementary Figure 1 TRAM-34 treatment with 10 mg/kg initiated 2 h after reperfusion and continued for 7 days twice daily noticeably reduced infarct area following similar reductions in cerebral blood flow (control: 51.2 ± 8.2% flux reduction, n = 10; TRAM-34: 49.0 ± 7.4% flux reduction, n = 11). (A) Analysis of each affected brain slice from 2 mm to 16 mm from the frontal pole of the brain, revealed a marked reduction of TTC-defined lesion areas in all slices, which was statistically significant in the 6, 8… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

11
110
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 100 publications
(124 citation statements)
references
References 46 publications
11
110
0
Order By: Relevance
“…We hypothesized that KCa3.1 channels are mechanistically involved in microglia/macrophage-mediated neuronal damage and demonstrate that both genetic deletion and pharmacological inhibition of KCa3.1 reduce infarct area and improve neurological deficit by reducing microglia/macrophagemediated neuronal killing and inflammatory cytokine production. These results significantly expand our previous findings in a rat model 14 by (1) À/À mice (Mouse Biology Program, UC Davis) were acclimatized to the new vivarium for 5 to 7 days before surgery. Animals were anesthetized using box induction with 5% isoflurane in medical grade oxygen and then maintained on 0.5 to 1.5% isoflurane via a facemask.…”
Section: Introductionsupporting
confidence: 82%
See 1 more Smart Citation
“…We hypothesized that KCa3.1 channels are mechanistically involved in microglia/macrophage-mediated neuronal damage and demonstrate that both genetic deletion and pharmacological inhibition of KCa3.1 reduce infarct area and improve neurological deficit by reducing microglia/macrophagemediated neuronal killing and inflammatory cytokine production. These results significantly expand our previous findings in a rat model 14 by (1) À/À mice (Mouse Biology Program, UC Davis) were acclimatized to the new vivarium for 5 to 7 days before surgery. Animals were anesthetized using box induction with 5% isoflurane in medical grade oxygen and then maintained on 0.5 to 1.5% isoflurane via a facemask.…”
Section: Introductionsupporting
confidence: 82%
“…17 Neurological deficits were scored according to a 4-score test 18 and a tactile and/or proprioceptive limb-placing test 19 as previously described. 14 …”
Section: Introductionmentioning
confidence: 99%
“…Reversible focal cerebral ischemia was induced by occlusion of the left middle cerebral artery (MCA) according to Zea Longa 24. Briefly, the left common carotid artery was exposed, the external carotid artery ligated distally from the common carotid artery, and a silicone rubber‐coated nylon monofilament with a tip diameter of 0.21 ± 0.02 mm for mice and of 0.43 ± 0.02 mm for rats (Doccol Corp.) inserted into the external carotid artery and advanced into the internal carotid artery to block the origin of the MCA 24, 25. The filament was kept in place for 60 min (mice) or 90 min (rats) and then withdrawn.…”
Section: Methodsmentioning
confidence: 99%
“…It can be autoclaved and allows for the dissolution of lipophilic compounds like PAP‐1 at high concentrations (5 and 20 mg/mL for this study). Neurological deficits were scored according to a tactile and proprioceptive limb‐placing test26 as previously described 25. The investigator performing the drug administration and neurological scoring was blinded to the treatments.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation